244 related articles for article (PubMed ID: 24515835)
1. Studies on the minor metabolite 6a-hydroxy-androstenedione for doping control purposes and its contribution to the steroid profile.
Polet M; Van Renterghem P; Van Gansbeke W; Van Eenoo P
Drug Test Anal; 2014 Oct; 6(10):978-84. PubMed ID: 24515835
[TBL] [Abstract][Full Text] [Related]
2. Detection of formestane abuse by mass spectrometric techniques.
de la Torre X; Colamonici C; Curcio D; Jardines D; Molaioni F; Parr MK; Botrè F
Drug Test Anal; 2014; 6(11-12):1133-40. PubMed ID: 25516450
[TBL] [Abstract][Full Text] [Related]
3. Searching for new markers of endogenous steroid administration in athletes: "looking outside the metabolic box".
Cawley AT; Hine ER; Trout GJ; George AV; Kazlauskas R
Forensic Sci Int; 2004 Jul; 143(2-3):103-14. PubMed ID: 15240029
[TBL] [Abstract][Full Text] [Related]
4. Investigations on carbon isotope ratios and concentrations of urinary formestane.
Piper T; Fusshöller G; Emery C; Schänzer W; Saugy M
Drug Test Anal; 2012 Dec; 4(12):942-50. PubMed ID: 22354842
[TBL] [Abstract][Full Text] [Related]
5. Hydrogen isotope ratio mass spectrometry and high-resolution/high-accuracy mass spectrometry in metabolite identification studies: detecting target compounds for sports drug testing.
Thevis M; Piper T; Horning S; Juchelka D; Schänzer W
Rapid Commun Mass Spectrom; 2013 Sep; 27(17):1904-12. PubMed ID: 23939956
[TBL] [Abstract][Full Text] [Related]
6. Influences of musk administration on the doping test.
He Y; Wang J; Liu X; Xu Y; He Z
Steroids; 2013 Nov; 78(11):1047-52. PubMed ID: 23891647
[TBL] [Abstract][Full Text] [Related]
7. Profiling of urinary steroids by gas chromatography-mass spectrometry detection and confirmation of androstenedione administration using isotope ratio mass spectrometry.
Wang J; Wu M; Liu X; Xu Y
Steroids; 2011 Dec; 76(14):1560-5. PubMed ID: 21945895
[TBL] [Abstract][Full Text] [Related]
8. The detection of androstenedione abuse in sport: a mass spectrometry strategy to identify the 4-hydroxyandrostenedione metabolite.
Cawley AT; Trout GJ; Kazlauskas R; George AV
Rapid Commun Mass Spectrom; 2008 Dec; 22(24):4147-57. PubMed ID: 19025884
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of boldione in humans by mass spectrometric techniques: detection of pseudoendogenous metabolites.
de la Torre X; Curcio D; Colamonici C; Molaioni F; Botrè F
Drug Test Anal; 2013; 5(11-12):834-42. PubMed ID: 24259377
[TBL] [Abstract][Full Text] [Related]
10. Drug testing data from the 2007 Pan American Games: delta13C values of urinary androsterone, etiocholanolone and androstanediols determined by GC/C/IRMS.
Aguilera R; Chapman TE; Pereira H; Oliveira GC; Illanes RP; Fernandes TF; Azevedo DA; Neto FA
J Steroid Biochem Mol Biol; 2009 Jul; 115(3-5):107-14. PubMed ID: 19428237
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a fast gas chromatography combustion isotope ratio mass spectrometry method for the detection of epiandrosterone sulfate in urine.
De Wilde L; Van Renterghem P; Van Eenoo P; Polet M
Drug Test Anal; 2020 Aug; 12(8):1006-1018. PubMed ID: 32267625
[TBL] [Abstract][Full Text] [Related]
12. Development of criteria for the detection of adrenosterone administration by gas chromatography-mass spectrometry and gas chromatography-combustion-isotope ratio mass spectrometry for doping control.
Brooker L; Parr MK; Cawley A; Flenker U; Howe C; Kazlauskas R; Schänzer W; George A
Drug Test Anal; 2009 Nov; 1(11-12):587-95. PubMed ID: 20355175
[TBL] [Abstract][Full Text] [Related]
13. IRMS delta values (
Brailsford AD; Majidin WNM; Wojek N; Cowan DA; Walker C
Drug Test Anal; 2018 Nov; 10(11-12):1722-1727. PubMed ID: 30381908
[TBL] [Abstract][Full Text] [Related]
14. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
Gosetti F; Mazzucco E; Gennaro MC; Marengo E
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
[TBL] [Abstract][Full Text] [Related]
15. Development of a GC/C/IRMS method--confirmation of a novel steroid profiling approach in doping control.
Van Renterghem P; Polet M; Brooker L; Van Gansbeke W; Van Eenoo P
Steroids; 2012 Sep; 77(11):1050-60. PubMed ID: 22728892
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal evaluation of the isotope ratio mass spectrometric data: towards the 'isotopic module' of the athlete biological passport?
Jardines D; Botrè F; Colamonici C; Curcio D; Procida G; de la Torre X
Drug Test Anal; 2016 Nov; 8(11-12):1212-1221. PubMed ID: 27732769
[TBL] [Abstract][Full Text] [Related]
17. Profiling of urinary formestane and confirmation by isotope ratio mass spectrometry.
Polet M; Van Renterghem P; Van Gansbeke W; Van Eenoo P
Steroids; 2013 Nov; 78(11):1103-9. PubMed ID: 23933120
[TBL] [Abstract][Full Text] [Related]
18. Analysis of exogenous nandrolone metabolite in horse urine by gas chromatography/combustion/carbon isotope ratio mass spectrometry.
Yamada M; Kinoshita K; Kurosawa M; Saito K; Nakazawa H
J Pharm Biomed Anal; 2007 Nov; 45(4):654-8. PubMed ID: 17714906
[TBL] [Abstract][Full Text] [Related]
19. Doping-control analysis of the 5alpha-reductase inhibitor finasteride: determination of its influence on urinary steroid profiles and detection of its major urinary metabolite.
Thevis M; Geyer H; Mareck U; Flenker U; Schänzer W
Ther Drug Monit; 2007 Apr; 29(2):236-47. PubMed ID: 17417080
[TBL] [Abstract][Full Text] [Related]
20. GC-C-IRMS in routine doping control practice: 3 years of drug testing data, quality control and evolution of the method.
Polet M; Van Eenoo P
Anal Bioanal Chem; 2015 Jun; 407(15):4397-409. PubMed ID: 25503937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
